From Jeff Passan and Tim Brown of Yahoo! Sports:
Milwaukee Brewers star Ryan Braun’s name is in records of the Miami-area clinic alleged to have distributed performance-enhancing drugs to a rash of baseball players, and Major League Baseball will investigate the link to the former MVP who tested positive for illegal synthetic testosterone during the 2011 postseason.
Braun was cleared of that 2011 positive test due to what was perceived to be an error in the handling of his urine sample. His name is not listed next to any specific PED transactions in the Biogenesis records, but Major League Baseball will investigate the matter in the hope of learning about the outfielder’s exact level of involvement.
Yankees catcher Francisco Cervelli and Orioles third baseman Danny Valencia were also discovered in the records at the Biogenesis clinic but, like Braun, were not listed in connection with a specific PED.
UPDATE, 11:21 PM: Braun says in a written statement that he used Bosch for consulting in his successful PED appeal and that he has “nothing to hide” —
“During the course of preparing for my successful appeal last year, my attorneys, who were previously familiar with Tony Bosch, used him as a consultant. More specifically, he answered questions about T/E ratio and possibilities of tampering with samples. There was a dispute over compensation for Bosch’s work, which is why my lawyer and I are listed under ‘moneys owed’ and not on any other list. I have nothing to hide and have never had any other relationship with Bosch. I will fully cooperate with any inquiry into this matter.”
The Yankees appear to have moved on from free agent Manny Machado this winter, but could they be turning their attention to Rockies superstar Nolan Arenado? That’s the idea floated by Andy Martino of SNY, who hears that GM Brian Cashman has been involved in recent discussions concerning the third baseman. No official comments have been made to the press yet, though, and it’s not clear whether the Yankees would prefer to pursue Arenado prior to the 2019 season or partway through it.
The 27-year-old infielder earned his fourth consecutive All-Star nomination, Silver Slugger, and Gold Glove award in 2018 after slashing .297/.374/.561 with 38 home runs, a .935 OPS, and 5.7 fWAR across 673 plate appearances. There’s no question he’s provided immense value to Colorado’s lineup over the last half-decade, and his consistency and incredible power at the plate helped form the basis of the record $30 million arbitration figure he presented to the team last week. The Rockies countered at $24 million, however, and in doing so may have jeopardized their chances of convincing the infielder to forego free agency in 2020 and take a long-term deal instead.
Assuming he declines to negotiate an extension with the Rockies, Arenado’s decorated résumé and career-best 2018 numbers should attract plenty of interest around the league — a reality that could put considerable pressure on the Yankees (or any other interested party) to finesse a deal sooner rather than later. For now, the club is prepared to enter the 2019 season with hot-hitting third baseman Miguel Andújar, whom Martino speculates would be the “centerpiece” of any trade with Colorado.